We review the evidence for optimal surgical management and adjuvant therapy for patients with stages I and II non-small cell lung cancer (NSCLC) along with factors associated with increased risks of recurrence. Based on the current evidence, we recommend optimal use of mediastinal lymph node dissection, adjuvant chemotherapy, and post-operative radiation therapy, and make suggestions for areas to explore in future prospective randomized clinical trials.
|Original language||English (US)|
|Number of pages||10|
|Journal||International Journal of Radiation Oncology Biology Physics|
|State||Published - Dec 1 2012|
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
- Cancer Research